3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
9
Breast Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
6
Prostatic Neoplasms
5
Lung Neoplasms
5
Hematologic Neoplasms
5
Sleep Initiation and Maintenance Disorders
4
Fatigue
4
Depression
4
Anxiety Disorders
4
Leukemia
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Breast Carcinoma In Situ
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Sleep Wake Disorders
2
Pancreatic Neoplasms
2
Pain
2
Myelodysplastic Syndromes
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
Interventions
Tomography, Emission-Computed, Single-Photon
1
Telescopes
1
Surveys and Questionnaires
1
Saline Solution
1
Radiosurgery
1
One-Lung Ventilation
1
Nutritional Status
1
Microscopy, Confocal
1
Health Records, Personal
1
Exercise
1
Drug Delivery Systems
1
Calcium Dobesilate
1
Bronchoscopy
1
Behavior Therapy
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lung Diseases
×
Behavior Therapy
×
Clear all
NCT04630743
2020-11-16
CoBeMEB
University of Cologne
Phase NA
Completed
49 enrolled